|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-60.00/-0.41
|
Enterprise Value
2.51M
|
Balance Sheet |
Book Value Per Share
18.88
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
1.38M
|
Operating Revenue Per Share
1.15
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/12/24 23:54 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients. |